Who is sponsoring NCT06809504?

NCT06809504 is sponsored by Hammad Mursaleen.

What drugs are being tested in NCT06809504?

Interventions in NCT06809504: Exercise based intervention.

What condition does NCT06809504 study?

NCT06809504 studies Substance Abuse Disorder.

Is NCT06809504 still recruiting?

NCT06809504 is currently completed. Last updated 5 February 2025.

Last reviewed 2025-02-05 · How we verify

NCT06809504

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

To Assess the Effectiveness of Structured Occupational Therapy (OT) Interventions on Patients With SUD in Inpatient Department (IPD) Settings, Focusing on Improvements in Cognitive, Physical, and Functional Domains

Completed NA Last updated 5 February 2025

What this trial tests

NA trial testing Exercise based intervention in Substance Abuse Disorder in 12 participants. Completed in 20 December 2024.

Timeline

14 April 2024

Primary endpoint
12 November 2024

20 December 2024

Quick facts

Lead sponsor	Hammad Mursaleen
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	12
Start date	14 April 2024
Primary completion	12 November 2024
Estimated completion	20 December 2024
Sites	1 location across Pakistan

Drugs / interventions tested

Exercise based intervention

Conditions studied

Substance Abuse Disorder — all drugs for Substance Abuse Disorder →

Sponsor

Hammad Mursaleen

Who can join

Under 55, any sex, with Substance Abuse Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

OT emphasis lies within the scope of improving daily life activities, cognitive and physical performance in order to regain the proper social role. This work assesses the impact of a 12 session structured OT intervention program for patients with SUD in IPD. Benefitting from checklists like the Montreal Cognitive Assessment (MoCA), the Barthel Index, the Lawton-Brody IADLs scale, it substantiates attaining enhancements in expressive cognitive functions, ADLs, and IADLs to understand how selected OT intervention modalities can enhance functional capabilities.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Substance Abuse Disorder

Currently open trials in the same condition.

NCT07417280 — LIFUS For Neurological Disorders · NA · recruiting
NCT06961838 — The Effect of Inspiratory Muscle Training With Substance Use Disorder · NA · recruiting
NCT05976672 — Machine Learning Technology in Predicting Relapse and Implementing Peer Recovery Intervention Before Drug Use Occurs · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06809504 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hammad Mursaleen
Last refreshed: 5 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06809504.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing